Breast Cancer Clinical Trials 2024

Breast Cancer Clinical Trials 2024

Breast Cancer research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in breast cancer clinical trials today.

Trials for LABC Patients

Trials for Ductal Carcinoma Patients

Trials for Metastatic Patients

Trials for ER Positive Patients

Trials for PR Positive Patients

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to breast cancer

What are the top hospitals conducting breast cancer research?

When it comes to cutting-edge clinical trials in the field of breast cancer, these top hospitals are leading the way. In Boston, the Dana-Farber Cancer Institute is setting an impressive example with nine active breast cancer trials and a remarkable history of 218 all-time trials dedicated to this condition. The institute's commitment to research dates back to its first recorded breast cancer trial in 1998, making it one of the pioneers in this crucial area.

Meanwhile, across state lines in New york City, Memorial Sloan Kettering Cancer Center stands as a beacon of hope for patients battling breast cancer. With eight ongoing breast cancer trials and an astounding record of 219 completed studies, this renowned institution has been at the forefront since their first recorded trial back in 1994.

Not too far from Boston lies Massachusetts General Hospital—a powerhouse when it comes to medical advancements and breakthroughs. Currently conducting seven active breast cancer trials while having completed a total of 157 studies over time shows their dedication towards fighting against this disease since recording their initial trial on this subject matter dating back until 1997.

Moving westward brings us to Washington University School of Medicine located in Saint Louis where they actively contribute through seven ongoing investigations on latest treatment methods available towards such cases which adds onto their already accomplished tally that sits at one hundred-thirty-seven; starting off with bringing forth progressive approaches by initiating investigation into potential treatments related solely towards combatting Breast Cancer around two decades prior (2000).

Lastly but not least significant Florida Cancer Specialists situated within Fort Myers plays key role whilst staying relatively smaller-scale; currently hosting six ongoing clinical tests focusing primarily on forward thinking yet practical solutions.Their proactive approach can be traced back almost three decades ago when they conducted initial pioneering investigations with relation only specificially targeting Breast Cancers starting from nineteen-ninety five.These respective institutions signify not just promises for individuals affected by Breast Cancers but also mark critical milestones toward advancement nationwide. The combined efforts of these top hospitals serve as a testament of human endeavor to understand this disease in its entirety and strive towards discovering breakthroughs that ensure brighter futures for countless patients around the world

Which are the best cities for breast cancer clinical trials?

When it comes to breast cancer clinical trials, several cities in the United States stand out for their active research initiatives. Boston, Massachusetts leads with 39 ongoing trials focusing on treatments like Enzalutamide, Trastuzumab emtansine (T-DM1), and PF-07220060. Nashville, Tennessee follows closely behind with 36 trials studying similar interventions. Houston, Texas and New york City also contribute significantly to breast cancer research with 32 and 31 active trials respectively. Additionally, Denver, Colorado is recognized for its dedication to advancing treatment options through 30 ongoing studies. These cities serve as key centers of innovation and provide valuable opportunities for patients seeking participation in breast cancer clinical trials.

Which are the top treatments for breast cancer being explored in clinical trials?

In the realm of breast cancer clinical trials, several top treatments have emerged as potential game-changers. Abemaciclib is taking center stage with its involvement in four active trials and a remarkable 65 all-time breast cancer trials since its introduction in 2014. Trastuzumab follows closely behind, also participating in four ongoing trials and an impressive history of 325 all-time breast cancer studies dating back to 2000. Another contender making waves is Olaparib, currently being explored in three active trials and boasting an extensive portfolio of 50 all-time breast cancer studies starting from 2010. Additionally, the promising Imlunestrant has caught researchers' attention with two active trials and three all-time breast cancer studies since its recent debut in 2021. These innovative treatments continue to pave the way for advancements against this relentless disease.

What are the most recent clinical trials for breast cancer?

Exciting advancements are being made in breast cancer research through recent clinical trials. One notable trial is exploring the effectiveness of a new treatment regimen for breast cancer patients, with promising results seen in Phase 2. Another study focuses on the use of injections at a specific dosage to target breast cancer cells, showing potential benefits during its Phase 1 stage. Additionally, researchers are investigating the efficacy of imlunestrant and elacestrant in separate Phase 3 and combined Phase 1/Phase 2 trials respectively. Finally, denosumab's potential role as a treatment option for breast cancer patients is being evaluated through an ongoing Phase 3 trial that began earlier this year. These endeavors bring hope for improved outcomes and novel therapeutic approaches to combat this challenging disease.

What breast cancer clinical trials were recently completed?

A multitude of recent clinical trials have made significant strides in the field of breast cancer research. Among them, G1 Therapeutics, Inc. completed a trial for Trilaciclib in November 2021, while HiberCell, Inc. concluded their study on Pembrolizumab during the same month. In July 2021, Mayo Clinic successfully wrapped up a trial investigating Probiotic treatment for breast cancer patients. Additionally, numerous other trials conducted by various institutions and organizations have contributed to expanding our understanding and potential treatment options for this devastating disease.